- Report
- November 2023
- 78 Pages
France
From €3111EUR$3,500USD£2,693GBP
- Report
- November 2023
- 190 Pages
Global
From €3999EUR$4,500USD£3,463GBP
- Report
- November 2023
- 78 Pages
Germany
From €3111EUR$3,500USD£2,693GBP
- Report
- March 2023
- 116 Pages
Global
From €3999EUR$4,500USD£3,463GBP
- Report
- December 2022
- 115 Pages
Global
From €3999EUR$4,500USD£3,463GBP
- Report
- January 2024
- 120 Pages
Global
From €7066EUR$7,950USD£6,117GBP
- Report
- May 2023
- 450 Pages
Global
From €4444EUR$5,000USD£3,847GBP
- Report
- June 2024
- 182 Pages
Global
From €3999EUR$4,500USD£3,463GBP
- Report
- February 2024
- 184 Pages
Global
From €3999EUR$4,500USD£3,463GBP
- Report
- November 2023
- 120 Pages
Asia Pacific
From €3555EUR$4,000USD£3,078GBP
- Report
- June 2024
- 200 Pages
Global
From €7066EUR$7,950USD£6,117GBP
- Report
- February 2024
- 200 Pages
Global
From €6666EUR$7,500USD£5,771GBP
- Report
- June 2022
- 120 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- January 2022
- 120 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 399 Pages
Global
From €8443EUR$9,500USD£7,310GBP
- Report
- April 2023
- 105 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- November 2023
- 77 Pages
France
From €3111EUR$3,500USD£2,693GBP
- Report
- May 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,193GBP
- Report
- May 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,193GBP
- Report
- May 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,193GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more